Pre-market
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$554.7K

Rothblatt Martine A Chairperson & CEO

Transaction date Oct 15, 2026
Public filing date Oct 16, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$541.51 Oct 15, 2026
First close after public filing
$543.15 Oct 19, 2026
Return after filing · so far
+9.67% Through Nov 11, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
1,009 shares @ $549.76
SEC ownership
Indirect
Transaction code
S
Form
4
Filing identifier
0001106578-26-000165
Filing cohort

Transactions in this filing

Showing 14 of 14
Trades
14
Issuers
1
Estimated value
$6.31M
Buys / sales
0 / 12
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Sale Oct 15, 2026 $450.35K
United Therapeutics Corp UTHR Sale Oct 15, 2026 $110.14K
United Therapeutics Corp UTHR Sale Oct 15, 2026 $1.12M
United Therapeutics Corp UTHR Current Sale Oct 15, 2026 $554.7K
United Therapeutics Corp UTHR Exercise Oct 15, 2026 $0
United Therapeutics Corp UTHR Sale Oct 15, 2026 $328.71K
United Therapeutics Corp UTHR Sale Oct 15, 2026 $151.87K
United Therapeutics Corp UTHR Sale Oct 15, 2026 $629.86K
United Therapeutics Corp UTHR Sale Oct 15, 2026 $247.46K
United Therapeutics Corp UTHR Sale Oct 15, 2026 $201.6K
United Therapeutics Corp UTHR Sale Oct 15, 2026 $146.54K
United Therapeutics Corp UTHR Sale Oct 15, 2026 $1.19M
United Therapeutics Corp UTHR Sale Oct 15, 2026 $66.18K
United Therapeutics Corp UTHR Exercise Oct 15, 2026 $1.12M